CoChat

Use of Citalopram in Pervasive Developmental Disorders

NAMEROW, LISA B., THOMAS, PRAKASH, BOSTIC, JEFF Q., PRINCE, JEFFERSON, MONUTEAUX, MICHAEL C. · 2003 · Journal of Developmental & Behavioral Pediatrics
Cited by 121

The DOI matches its Crossref record.

Abstract

This study assessed the effectiveness and tolerability of the selective serotonin reuptake inhibitor citalopram in the treatment of patients with pervasive developmental disorders (PDDs). The medical charts of 15 children and adolescents (aged 6-16 yr) with Asperger syndrome, autism, or PDD not otherwise specified treated with citalopram were retrospectively reviewed. The final dose of citalopram was 16.9 +/- 12.1 mg/day with a treatment duration of 218.8 +/- 167.2 days. Independent ratings of the Clinical Global Impression (CGI) Severity and Improvement scales allowed comparison between baseline and PDD symptoms at the last visit. Eleven adolescents (73%) exhibited significant improvement in PDD, anxiety, or mood CGI score (z = 2.95; p =.003). Anxiety symptoms associated with PDDs improved significantly in 66% of patients (z = 2.83, p =.005), and mood symptoms improved significantly in 47% of patients (z = 2.78, p =.005). Mild side effects were reported by five patients (33%). These data suggest citalopram may be effective, safe, and well tolerated as part of the treatment of PDDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004703-200304000-00005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 23

  1. Marazziti, 2000, Pharmacopsychiatry, 33, 165, 10.1055/s-2000-7588 · DOI · Paper page
  2. Croonenberghs, 2000, Neuropsychopharmacology, 22, 275, 10.1016/S0893-133X(99)00131-1 · DOI
  3. McDougle, 2000, J Autism Dev Disord, 30, 427, 10.1023/A:1005551523657 · DOI · Paper page
  4. McDougle, 1996, Arch Gen Psychiatry, 53, 1001, 10.1001/archpsyc.1996.01830110037005 · DOI · Paper page
  5. Cook, 1992, J Am Acad Child Adolesc Psychiatry, 31, 739, 10.1097/00004583-199207000-00024 · DOI · Paper page
  6. Fatemi, 1998, J Autism Dev Disord, 28, 303, 10.1023/A:1026008602540 · DOI
  7. DeLong, 1998, Dev Med Child Neurol, 40, 551, 10.1111/j.1469-8749.1998.tb15414.x · DOI · Paper page
  8. Alcami Pertejo, 2000, Actas Esp Psiquiatr, 28, 353
  9. Hellings, 1996, J Clin Psychiatry, 57, 333
  10. McDougle, 1998, Arch Gen Psychiatry, 55, 633, 10.1001/archpsyc.55.7.633 · DOI · Paper page
  11. Steingard, 1997, J Child Adolesc Psychopharmacol, 7, 9, 10.1089/cap.1997.7.9 · DOI · Paper page
  12. Willetts, 1999, J Clin Psychopharmacol, 19, 36S, 10.1097/00004714-199910001-00004 · DOI
  13. Gutierrez, 2000, Pharmacotherapy, 20, 1441, 10.1592/phco.20.19.1441.34851 · DOI · Paper page
  14. Baumann, 1995, Int Clin Psychopharmacol, 10, 15, 10.1097/00004850-199503001-00004 · DOI
  15. von Moltke, 1999, Biol Psychiatry, 46, 839, 10.1016/S0006-3223(98)00353-9 · DOI
  16. Arnold, 2000, J Autism Dev Disord, 30, 99, 10.1023/A:1005451304303 · DOI
  17. Thomsen, 2001, J Am Acad Child Adolesc Psychiatry, 40, 895, 10.1097/00004583-200108000-00010 · DOI
  18. Bostic, 2001, J Child Adolesc Psychopharmacol, 11, 159, 10.1089/104454601750284063 · DOI
  19. Schaller, 2001, Med Gen Med, 3, 1, 10.1002/1521-2254(200101/02)3:1<1::AID-JGM170>3.0.CO;2-6 · doi:10.1002/1521-2254(200101/02)3:1<1::aid-jgm170>3.0.co;2-6
  20. Peral, 1999, J Am Acad Child Adolesc Psychiatry, 38, 1472, 10.1097/00004583-199912000-00005 · DOI
  21. Hollander, 2000, J Child Neurol, 15, 132, 10.1177/088307380001500214 · DOI · Paper page
  22. Posey, 2001, J Child Adolesc Psychopharmacol, 11, 267, 10.1089/10445460152595586 · DOI · Paper page
  23. Montgomery, 1994, Int Clin Psychopharmacol, 9, 35, 10.1097/00004850-199403001-00006 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
NAMEROW, L. B., THOMAS, P., BOSTIC, J. Q., PRINCE, J., & MONUTEAUX, M. C.
Venue
Journal of Developmental & Behavioral Pediatrics
Published
2003-04
Volume
24
Issue
2
Pages
104-108
ISSN
0196-206X (ISSN-L)
OpenAlex
W1978189785
Cited by
121
References
0
FWCI
3.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of Citalopram in Pervasive Developmental Disorders. https://app.cochat.ai/papers/10.1097/00004703-200304000-00005
The paper
NAMEROW, L. B., THOMAS, P., BOSTIC, J. Q., PRINCE, J., & MONUTEAUX, M. C. (2003). Use of Citalopram in Pervasive Developmental Disorders. Journal of Developmental & Behavioral Pediatrics. https://doi.org/10.1097/00004703-200304000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.